William Waddill
Director/Board Member at ANNEXON, INC.
Net worth: 1 M $ as of 2024-04-29
William Waddill active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 2016-06-30 | - |
| Independent Dir/Board Member | 2016-06-30 | - | |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2017-12-31 | - |
| Independent Dir/Board Member | 2017-12-31 | - | |
| ANNEXON, INC. | Director/Board Member | 2021-08-11 | - |
| Independent Dir/Board Member | 2021-08-11 | - | |
| TURNSTONE BIOLOGICS CORP. | Director/Board Member | 2024-04-14 | - |
| Independent Dir/Board Member | 2024-04-14 | - | |
| Annexon Biosciences, Inc. | Director/Board Member | - | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - | - |
Career history of William Waddill
Former positions of William Waddill
| Companies | Position | Start | End |
|---|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Director of Finance/CFO | 2014-03-31 | 2016-12-30 |
| Corporate Secretary | 2014-03-31 | 2016-12-30 | |
| Treasurer | 2014-03-31 | 2016-12-30 | |
| ONCOMED PHARMACEUTICALS INC | Director of Finance/CFO | 2007-09-30 | 2014-03-30 |
| Treasurer | 2007-09-30 | 2014-03-30 | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Director of Finance/CFO | 2006-09-30 | 2007-08-31 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of William Waddill
| University of Illinois | Undergraduate Degree |
Statistics
International
| United States | 15 |
| New Zealand | 2 |
| Canada | 2 |
Operational
| Director/Board Member | 9 |
| Director of Finance/CFO | 5 |
| Independent Dir/Board Member | 4 |
Sectoral
| Health Technology | 11 |
| Commercial Services | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 6 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 10 |
|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Ilypsa, Inc.
Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Deloitte & Touche, Inc.
 Deloitte & Touche, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte & Touche, Inc. provides accounting services. The company is based in Calgary, Canada. | Commercial Services |
Medical Science Partners LP
 Medical Science Partners LP Investment ManagersFinance Profile unavailable. | Finance |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
| Annexon Biosciences, Inc. |
- Stock Market
- Insiders
- William Waddill
- Experience